10x Genomics and Lausanne University Hospital Partner for Cancer Diagnostic Research
The collaboration will use single-cell and spatial biology platforms to identify biomarkers that predict treatment response in solid tumors.
Category: Company News
Company News
Latest
Company News
Latest
Myriad Genetics Launches New Four-in-One Prenatal Genetic Screen
Myriad Genetics has launched the FirstGene Multiple Prenatal Screen, a test that combines four prenatal genetic screens from a single blood draw as early as eight weeks gestation, according to the company.
Company News
Latest
Roche to Share New Data on Elecsys Alzheimer’s Blood Tests at AAIC
Presentations will evaluate the performance of the company's pTau217 and pTau181 assays while also highlighting phase 3 clinical research for the investigational therapy trontinemab for Alzheimer's disease.
Eurobio Scientific Finalizes Acquisition of CareDx Lab Product Division
The transaction includes subsidiaries in the United States, Sweden, and Australia to expand transplantation diagnostic offerings.
Read More
UnitedHealth Group Covers Shield Blood Test for Colorectal Cancer Screening
The Shield test is now available to eligible members aged 45 and older, expanding access to screening options for colorectal cancer.
Read More
ADLM Names New Leadership for 2026
Christina Lockwood, PhD, will serve as president-elect starting in August 2026, followed by a term as president in 2027.
Read More
Pictor Holdings Secures $7.5 Million to Expand Protein Analysis Platform
The funding will support manufacturing and commercial partnerships for a system that analyzes multiple protein targets in less than two hours.
Read More
InterVenn, Aranscia Expand Access to Blood-Based Ovarian Cancer Test
The expanded commercialization agreement aims to increase availability of the GlycoKnow Ovarian laboratory-developed test through Aranscia’s clinical workflow and technology platforms.
Read More
Allarity Secures US Patent for Ovarian Cancer Companion Diagnostic Test
The patent covers a gene-expression profiling method designed to identify patients most likely to respond to the investigational therapy stenoparib through 2042.
Read More
HerAnova Presents Validation Data for Endometriosis Blood Test
HerAnova Lifesciences presented validation data for HerResolve, a blood-based endometriosis test, showing 94.4% accuracy and detection of cases missed by imaging.
Read More
National Coverage Agreement Secured for Cerebrospinal Fluid Cancer Test
CNSide Diagnostics has secured a national agreement with Elevance Health, expanding access to its CSF Tumor Cell Enumeration assay to 45.4 million more people in the US, Plus Therapeutics announced.
Read More
GRAIL Secures $110 Million Investment from Samsung
GRAIL secured $110 million in equity financing from Samsung affiliates to support U.S. regulatory efforts and expand its Galleri multi-cancer early detection test into Asian markets, the companies announced.
Read More
Countable Labs and Promega Partner for Sample Preparation and Rare Variant Detection
The agreement combines extraction and PCR technologies to create an end-to-end workflow for DNA and RNA analysis.
Read More
Tecan and NVIDIA Integrate New Artificial Intelligence Capabilities into Lab Analytics Platform
Tecan has integrated agentic AI, powered by NVIDIA’s BioNeMo Agent Toolkit, into its Introspect laboratory analytics platform to enable proactive operations and improve productivity in clinical labs.
Read More
Quest Gains New York Approval for Haystack MRD Cancer Monitoring Test
The approval allows Quest Diagnostics to offer its minimal residual disease test for patients in all 50 states.
Read More
Early Lung Cancer Blood Test Completes US Laboratory Validation
The CIZ1B biomarker assay is designed to complement LDCT screening by helping assess lung cancer risk and clarify indeterminate findings.
Read More
Agilent Partners with OpenAI and BCG to Advance Artificial Intelligence in Lab Workflows
Agilent Technologies has partnered with OpenAI and Boston Consulting Group to accelerate artificial intelligence deployment in lab workflows, aiming to deliver faster scientific insights and advance intelligent instruments, software, and services.
Read More
Labcorp Expands DPYD Test to Identify Chemotherapy Toxicity Risk
The updated test includes additional DPYD variants recommended by the Association for Molecular Pathology to help identify patients who may be at risk for severe chemotherapy side effects.
Read More